BALYASNY ASSET MANAGEMENT L.P. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$25,000
+127.3%
20,611
+20.4%
0.00%
Q2 2022$11,000
-79.6%
17,123
+1.5%
0.00%
Q1 2021$54,000
+38.5%
16,873
-12.7%
0.00%
Q4 2017$39,000
-99.4%
19,325
-95.3%
0.00%
-100.0%
Q4 2014$6,970,000
+98.6%
412,656
+49.8%
0.06%
+60.0%
Q2 2014$3,509,000275,4210.04%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 7,866,108$25,408,0004.32%
Nine Chapters Capital Management LLC 91,500$296,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,969,225$6,361,0000.24%
Orbimed Advisors 3,250,300$10,498,0000.12%
PINNACLE ASSOCIATES LTD 1,306,679$4,221,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 810,232$2,617,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 270,417$873,0000.06%
Rock Springs Capital Management LP 270,000$872,0000.05%
ALGERT GLOBAL LLC 39,876$129,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 391,671$1,265,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders